GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » EV-to-FCF

BITGF (Biotage AB) EV-to-FCF : 50.42 (As of Dec. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Biotage AB's Enterprise Value is $1,186.4 Mil. Biotage AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $23.5 Mil. Therefore, Biotage AB's EV-to-FCF for today is 50.42.

The historical rank and industry rank for Biotage AB's EV-to-FCF or its related term are showing as below:

BITGF' s EV-to-FCF Range Over the Past 10 Years
Min: 11.86   Med: 44.55   Max: 90.22
Current: 52.69

During the past 13 years, the highest EV-to-FCF of Biotage AB was 90.22. The lowest was 11.86. And the median was 44.55.

BITGF's EV-to-FCF is ranked worse than
69.17% of 373 companies
in the Medical Devices & Instruments industry
Industry Median: 28.76 vs BITGF: 52.69

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Biotage AB's stock price is $14.80. Biotage AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.320. Therefore, Biotage AB's PE Ratio (TTM) for today is 46.25.


Biotage AB EV-to-FCF Historical Data

The historical data trend for Biotage AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB EV-to-FCF Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.91 40.61 57.84 44.34 53.69

Biotage AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.43 53.69 53.25 49.75 61.26

Competitive Comparison of Biotage AB's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Biotage AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Biotage AB's EV-to-FCF falls into.



Biotage AB EV-to-FCF Calculation

Biotage AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1186.375/23.531
=50.42

Biotage AB's current Enterprise Value is $1,186.4 Mil.
Biotage AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotage AB  (OTCPK:BITGF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Biotage AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.80/0.320
=46.25

Biotage AB's share price for today is $14.80.
Biotage AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.320.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Biotage AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Biotage AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines